Robot-assisted hip replacement for Legg-Calve-Perthes disease
Part of Bones, joints & muscles clinical trials.
This trial compares robot-assisted total hip replacement to the usual surgery for people with Legg-Calve-Perthes disease. It aims to see if the robotic arm helps the surgery go more smoothly.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with Legg-Calve-Perthes disease.
- You are scheduled for total hip replacement surgery.
- You do not have an active infection.
- You are able to complete all follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows children (and teens) with Legg-Calvé-Perthes disease to learn about how today’s treatments work in real life. It may help doctors choose the best next steps for your child’s hip health.
This trial compares a robot-assisted knee replacement technique to the standard approach for people with severe knee arthritis. It aims to see which method leads to better recovery and outcomes.
This study tests if robot-assisted total knee replacement surgery is safe and effective. It may help people who need knee replacement surgery by using advanced technology for more precise implant placement.
This study compares robot-assisted knee replacement surgery to the standard procedure. Both groups will do a virtual home-based rehabilitation program. It aims to see if one approach leads to better recovery and outcomes.
This study tests a robot-assisted knee replacement using a new type of implant designed to move more like a natural knee. It may help people with arthritis or other knee joint problems who need a total knee replacement.
This trial tests two types of knee implants during robot-assisted surgery. It aims to see which one works better for people needing a first-time total knee replacement due to arthritis or similar conditions.
Hear when a new Legg-Calvé-Perthes Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.